Get started
AFT PHARMACEUTICALS LTD NPVAFT PHARMACEUTICALS LTD NPVAFT PHARMACEUTICALS LTD NPV

AFT PHARMACEUTICALS LTD NPV

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

AFT chart


Full chart

AFT upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪266.36 M‬ NZD
Dividend yield (indicated)
0.63%
Price to earnings Ratio (TTM)
23.94
Basic EPS (TTM)
0.11 NZD
Net income (FY)
‪15.61 M‬ NZD
Revenue (FY)
‪195.41 M‬ NZD
Shares float
‪28.38 M‬
Beta (1Y)
0.36

Employees


Employees (FY)
110
Change (1Y)
+10 +10.00%
Revenue / Employee (1Y)
‪1.06 M‬ NZD
Net income / Employee (1Y)
‪84.81 K‬ NZD

About AFT PHARMACEUTICALS LTD NPV


Sector
Health Technology
CEO
Hartley Atkinson
Headquarters
Auckland
Website
aftpharm.com
Founded
1997
ISIN
NZAFTE0001S4
FIGI
BBG00BM48VJ5
AFT Pharmaceuticals Ltd. engages in the development, licensing, and distribution of medical and pharmaceutical products. It operates through the following geographical segments: Australia, New Zealand, Asia, and Rest of the World. The Australia segment caters to the Australian market. The New Zealand segment focuses on the head office function, supplier relationships and procurement of stock, and regulatory, marketing, and finance activities of the group. The Asia segment relates in the sales activities in Brunei, Hong Kong, Malaysia, Philippines, Singapore, and Vietnam markets. The Rest of the World segment consists of out licensing of internet protocol developments to markets in which the firm does not have a presence and the export of products to export markets. The company was founded by Hartley Atkinson and Marree Atkinson on September 4, 1997 and is headquartered in Auckland, New Zealand.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

AFT news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of AFT is 2.71 NZD — it has increased by 2.26% in the past 24 hours. Watch AFT PHARMACEUTICALS LTD NPV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NZX exchange AFT PHARMACEUTICALS LTD NPV stocks are traded under the ticker AFT.
AFT stock has risen by 9.27% compared to the previous week, the month change is a −18.62% fall, over the last year AFT PHARMACEUTICALS LTD NPV has showed a −17.88% decrease.
We've gathered analysts' opinions on AFT PHARMACEUTICALS LTD NPV future price: according to them, AFT price has a max estimate of 4.45 NZD and a min estimate of 3.00 NZD. Watch AFT chart and read a more detailed AFT PHARMACEUTICALS LTD NPV stock forecast: see what analysts think of AFT PHARMACEUTICALS LTD NPV and suggest that you do with its stocks.
AFT reached its all-time high on Nov 10, 2020 with the price of 5.65 NZD, and its all-time low was 1.70 NZD and was reached on Apr 16, 2019. View more price dynamics on AFT chart.
See other stocks reaching their highest and lowest prices.
AFT stock is 2.64% volatile and has beta coefficient of 0.36. Track AFT PHARMACEUTICALS LTD NPV stock price on the chart and check out the list of the most volatile stocks — is AFT PHARMACEUTICALS LTD NPV there?
Today AFT PHARMACEUTICALS LTD NPV has the market capitalization of ‪277.89 M‬, it has increased by 2.42% over the last week.
Yes, you can track AFT PHARMACEUTICALS LTD NPV financials in yearly and quarterly reports right on TradingView.
AFT PHARMACEUTICALS LTD NPV is going to release the next earnings report on May 22, 2025. Keep track of upcoming events with our Earnings Calendar.
AFT PHARMACEUTICALS LTD NPV revenue for the last half-year amounts to ‪86.71 M‬ NZD, despite the estimated figure of ‪96.10 M‬ NZD. In the next half-year revenue is expected to reach ‪127.60 M‬ NZD.
AFT net income for the last half-year is ‪−2.19 M‬ NZD, while the previous report showed ‪13.79 M‬ NZD of net income which accounts for −115.85% change. Track more AFT PHARMACEUTICALS LTD NPV financial stats to get the full picture.
Yes, AFT dividends are paid annually. The last dividend per share was 0.02 NZD. As of today, Dividend Yield (TTM)% is 0.60%. Tracking AFT PHARMACEUTICALS LTD NPV dividends might help you take more informed decisions.
AFT PHARMACEUTICALS LTD NPV dividend yield was 0.51% in 2023, and payout ratio reached 10.75%. The year before the numbers were 0.32% and 10.83% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 22, 2024, the company has 110.00 employees. See our rating of the largest employees — is AFT PHARMACEUTICALS LTD NPV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AFT PHARMACEUTICALS LTD NPV EBITDA is ‪21.05 M‬ NZD, and current EBITDA margin is 13.16%. See more stats in AFT PHARMACEUTICALS LTD NPV financial statements.
Like other stocks, AFT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AFT PHARMACEUTICALS LTD NPV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AFT PHARMACEUTICALS LTD NPV technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AFT PHARMACEUTICALS LTD NPV stock shows the strong sell signal. See more of AFT PHARMACEUTICALS LTD NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.